KIMS Q3 Results Review - Strong Operating Cash Flows, ROCE: Axis Securities
2 months ago•Bloomberg Quint
Buy Krishna Institute of Medical Sciences; target of Rs 2000: Prabhudas Lilladher
5 months ago•Moneycontrol
Corporate hospitals to see 8-10 pc revenue growth in FY24: Report
8 months ago•Economic Times
Buy Krishna Institute of Medical Sciences; target of Rs 2000: Prabhudas Lilladher
8 months ago•Moneycontrol
Buy Krishna Institute of Medical Sciences., target price Rs 1950: Jayesh Bhanushali
8 months ago•Economic Times
KIMS declines despite a profitable Q1
8 months ago•Moneycontrol
KIMS to double number of beds to 8,000 in 2 years
8 months ago•The Hindu Businessline